A	B	C	D	E	F	G	H	I	J	K	L	M	N	O	P	Q	R	S	T	U	V	W	X	Y	Z	AA	AB	AC
1	Main
2		Brand Name	Prevnar, Prevanar-13, Prevanar, Prevenar 20, Prevnar 20, Apexxnar
3		Generic Name	Pneumococcal 7-valent conjugate vaccine.
4		Indication	Pneumococcal Disease. Adults vs pediatric.
5		Mechanism	Vaccine
6		Administration	IM
7		Regulatory	11/94 IND. 6/1/99 application (PLA). 2/2000 approval.
8			Prevanar 13 approval.
9			Prevnar 20 approved by EMA 2/2022
10		IP	6921537 describes Prevnar process?
11		Competition	Synflorix is 10-valent. http://www.emea.europa.eu/humandocs/Humans/EPAR/synflorix/synflorix.htm
12		Launches	Prevanar-13 launches in India - July 2010. 370,000 infant deaths due to pneumonia annually. 25m births annually. 15,000 Rs price.
13		Model
14
15			2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020		Q409	Q110	Q210	Q310	Q410	Q111	Q211	Q311	Q411	Q112
16		Total WW Revenue	1508	1961	2439	2716	2888	3669	4145											287	806	900	914	1049	1149	976	1104	916	1079
17		Total US Revenue						1975	1928											144	389	516	540	530	651	428	454	395	554
18		Total ExUS Revenue						1694	2217											143	417	384	374	519	498	548	650	521	525
19		WW P13						2416	3657											0	286	569	735	826	996	821	1006	834	941
20		US P13						1761	1928											0	208	483	540	530	651	428	454	395	554
21		ExUS P13						655	1729											0	78	86	195	296	345	393	552	439	387
22		WW P7						1253	488											287	520	331	179	223	153	155	98	82	138
23		US P7						214	0											144	181	33	0	0	0	0	0	0	0
24		ExUS P7						1039	488											143	339	298	179	223	153	155	98	82	138
25
26		Total WW Growth																						2.6550522648083623	0.4255583126550868	0.08444444444444454	0.20787746170678334	-0.12678741658722592	-0.060922541340295955
27		Total US Growth																						2.6805555555555554	0.6735218508997429	-0.1705426356589147	-0.1592592592592592	-0.2547169811320755	-0.14900153609831024
28		Total ExUS Growth																						2.629370629370629	0.19424460431654667	0.42708333333333326	0.7379679144385027	0.003853564547206201	0.054216867469879526
29		WW P13 Growth																						-	2.4825174825174825	0.4428822495606326	0.36870748299319733	0.009685230024213176	-0.05522088353413657
30		US P13 Growth																						-	2.1298076923076925	-0.11387163561076608	-0.1592592592592592	-0.2547169811320755	-0.14900153609831024
31		ExUS P13 Growth																						-	3.4230769230769234	3.5697674418604652	1.830769230769231	0.4831081081081081	0.12173913043478257
32		WW P7 Growth																						-0.22299651567944256	-0.7057692307692307	-0.5317220543806647	-0.45251396648044695	-0.6322869955156951	-0.0980392156862745
33		US P7 Growth																						-	-	-	-	-	-
34		ExUS P7 Growth																						0.5594405594405594	-0.5486725663716814	-0.47986577181208057	-0.45251396648044695	-0.6322869955156951	-0.0980392156862745
35
36		Prevnar 13 US Price						102.03	102.03
37		Prevnar 13 US Doses						17259.6295207292	18896.403018719982
38
39		Birth Cohort						4000	4000
40		Birth Revenue						408.12	408.12